Department of Pharmaceutical Sciences, Hemvati Nandan Bahuguna Garhwal University (Central University), Srinagar, India.
Department of Botany, Hariom Saraswati PG College, Dhanauri, Haridwar, Uttarakhand, India.
Chem Biol Drug Des. 2024 Jun;103(6):e14561. doi: 10.1111/cbdd.14561.
The present review article thoroughly analyses natural products and their derived phytoconstituents as a rich source of plausible anticancer drugs. The study thoroughly explores the chemical components derived from various natural sources, thus emphasizing their unique structural characteristics and therapeutic potential as an anticancer agent. The review contains the critical chemical constituents' in-depth molecular mechanisms, their source's chemical structures and the categories. The review also comprises an exhaustive and comprehensive analysis of different chemical spacing parameters of the anticancer agents derived from natural products. It compares them with USFDA-approved synthetic anticancer drugs up to 2020, thus providing a meaningful understanding of the relationship between natural and synthetic compounds portraying the anticancer assets. The review also delves more deeply into the chemical analysis of the heterocyclic moieties from the natural product arena, illustrating the anticancer mechanisms. The present article is, therefore, expected to serve as a valuable resource for natural product and medicinal chemists, encouraging and promoting an integrated approach to exploit the potential of natural products in drug discovery development and translational research, which have a prerequisite of bench to bedside approach. The work could guide researchers toward innovative approaches for the ever-evolving field of anticancer drug discovery.
本文深入分析了天然产物及其衍生的植物成分,它们是合理的抗癌药物的丰富来源。本研究深入探讨了源自各种天然来源的化学成分,从而强调了它们作为抗癌剂的独特结构特征和治疗潜力。本综述包含关键化学成分的深入分子机制、它们的来源的化学结构和类别。本综述还包括对天然产物衍生的不同化学间隔参数的抗癌剂的详尽和全面分析。它将其与截至 2020 年美国 FDA 批准的合成抗癌药物进行了比较,从而对天然和合成化合物在描绘抗癌资产方面的关系有了更深入的了解。本综述还更深入地探讨了天然产物领域中杂环部分的化学分析,阐明了抗癌机制。因此,本文有望成为天然产物和药物化学家的宝贵资源,鼓励并促进综合方法的应用,以开发药物发现开发和转化研究中的天然产物潜力,这需要从实验室到病床的方法。这项工作可以为不断发展的抗癌药物发现领域的研究人员提供创新方法。